Skip to main content

Day: November 13, 2019

Teligent, Inc. to Present at Jefferies Global Healthcare Conference in London on Wednesday November 20, 2019

BUENA, N.J., Nov. 13, 2019 (GLOBE NEWSWIRE) — Teligent, Inc. (NASDAQ: TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at Jefferies Global Healthcare Conference. The Conference is taking place November 20-21, 2019 in London, UK.Jason Grenfell-Gardner, Chief Executive Officer of Teligent, Inc., will present on Wednesday November 20th at 4:40 p.m. GMT+1. The presentation will be webcast and accessible online via the investors section of the Company’s website at www.teligent.com.  A replay will be available for 30 days.  About Teligent, Inc.Teligent is a specialty generic pharmaceutical company.  Our mission is to be a leading player in the specialty generic prescription drug market.  Learn more on our website www.teligent.com.Contact:         Damian FinioTeligent, Inc.(856) 336-9117www....

Continue reading

Christian Dior: Financial release Interim Dividend

Paris, November 13, 2019FINANCIAL RELEASEINTERIM DIVIDENDAt a meeting held today, the Board of Directors of Christian Dior approved, in the context of the transactions completed in 2017, the distribution of the Company’s net cash surplus resulting from the sale of the Christian Dior Couture segment.This interim dividend, for a gross amount of €29.20 per share, will be paid as of December 10, 2019.Including the interim dividend of €2.20 per share previously approved on July 24, 2019, the total gross amount paid as of December 10, 2019 will be €31.40 per Christian Dior share.This financial release is available on our website: www.dior-finance.comAttachmentChristian Dior Communiqué 13 11 2019 VA

Continue reading

Christian Dior : Communiqué financier Acompte sur Dividende

Paris, le 13 novembre 2019COMMUNIQUE FINANCIERACOMPTE SUR DIVIDENDELe Conseil d’administration de Christian Dior s’est réuni ce jour et a décidé, dans le prolongement des opérations de 2017, de procéder à la distribution de la trésorerie nette excédentaire de la Société issue de la cession de la branche Christian Dior Couture.Cet acompte sur dividende, d’un montant brut de 29,20 € par action, sera mis en paiement le 10 décembre 2019.Compte tenu de l’acompte sur dividende de 2,20 euros par action précédemment décidé le 24 juillet 2019, le montant brut total mis en paiement le 10 décembre 2019 sera de 31,40 € par action Christian Dior.Ce communiqué est disponible sur le site web www.dior-finance.comPièce jointeChristian Dior Communiqué 13 11 2019

Continue reading

The DOVE Channel Delivers a Sleigh-Full of Festive Family Favorites Just in Time for the Holidays

The Lineup Includes Elizabeth Banks in Lovely Still; David, Donny, & Marie Osmond in A Wonderama Christmas; Jim O’Heir in Naughty & Nice, & MoreViewers Can Enjoy DOVE All Year Long for Just $19.99 with the Special “Deck the Halls with DOVE” OfferLOS ANGELES, Nov. 13, 2019 (GLOBE NEWSWIRE) — The DOVE Channel is comin’ to town with a winter wonderland of festive family-friendly favorites, as the faith-based digital-first Cinedigm (CIDM) network gets viewers into the spirit of the season with a star-studded lineup featuring 40 Yuletide classics. As part of this special event, DOVE Channel is giving viewers a chance to enjoy premium programming for the whole family all year long with the “Deck The Halls With DOVE” offer—available for just $19.99.Starting today, DOVE viewers can experience a roster of beloved films that...

Continue reading

eGain launches AI-guided knowledge solution for omnichannel engagement in the Salesforce ecosystem

SUNNYVALE, Calif., Nov. 13, 2019 (GLOBE NEWSWIRE) — eGain (NASDAQ: EGAN), the leading provider of omnichannel customer engagement solutions, today launched eGain for Sales Force, Fall 2019 Edition. Powered by AI and knowledge and embedded in the Salesforce agent console, the solution delivers easy omnichannel customer engagement for service and sales. The company will give away free, production pilots for the solution as part of its Innovation in 30 Days™ offering1 at Dreamforce 2019: Campground Booth #437.As self-service gets smarter, contact center agents are left to deal with complex queries and emotional escalations. Embedded in Salesforce agent console, eGain for Salesforce contextually bootstraps knowledge search and AI guidance to proactively empower agents. Clients love the ease and efficacy of eGain omnichannel guidance...

Continue reading

Monica Enand Joins NW Natural Holding Company Board of Directors

PORTLAND, Ore., Nov. 13, 2019 (GLOBE NEWSWIRE) — The board of directors of Northwest Natural Holding Company, (NYSE: NWN) (NW Natural Holdings), elected Monica Enand to the board starting November 12, 2019.In 2008, Enand founded Zapproved, a cloud-based software provider for corporate legal departments, where she currently serves as chief executive officer. Before founding Zapproved, she was the director of business development and marketing at Avnera Corporation, a fabless semiconductor manufacturer. Enand also held sales and marketing positions at IBM and was a program manager in the Compiler and Architecture Group at Intel.Enand chairs the boards of directors of Auth0, is a board member of Oregon Business Council, and is immediate past president of the Technology Association of Oregon. She previously served on the Oregon Growth...

Continue reading

New tools from Xero put profitability in the business’ hands

LONDON, Nov. 13, 2019 (GLOBE NEWSWIRE) — Xero, the global small business platform, today unveiled new features that help small businesses better understand their finances, manage projects’ profitability and complete payroll benefits faster.Xero has invested heavily in the past year to expand  its small business products beyond core accounting services to help small businesses better manage their staff, operate and scale.The new features announced today at Xerocon London 2019, where over 3,000 partners have gathered, expand its broader small business product range and include:Real-time, smarter insights with Business Snapshot: A new tool to go into pilot early next year, Business Snapshot gives small business owners an important, high-level view of their critical business metrics and important trends using beautiful visualisations...

Continue reading

LogistiCare Contracts with PacificSource Community Solutions to Provide Non-Emergency Medical Transportation in two Oregon counties

Atlanta, Nov. 13, 2019 (GLOBE NEWSWIRE) — LogistiCare, the nation’s largest non-emergency medical transportation (NEMT) broker, today announced it has contracted with PacificSource Community Solutions to serve the coordinated care organization’s (CCO) 100,000 members in Oregon’s Marion and Polk counties, beginning Jan. 1, 2020.“We are elated to have entered into this agreement and look forward to continuing to fulfil the transportation needs of Oregonians, many of whom are among the most frail and vulnerable,” said LogistiCare CEO Carter Pate. “LogistiCare has provided NEMT services in Marion and Polk counties under a different CCO for the past two years. We are committed to providing a seamless transition with the exceptional level of service our members have come to expect.”Together with the newly acquired Circulation technology,...

Continue reading

Valneva Announces Appointments of Two Leading Vaccine Experts to its Scientific Advisory Board

Valneva Announces Appointments of Two Leading Vaccine Experts to its Scientific Advisory Board  Saint Herblain (France), November 13, 2019 – Valneva SE (“Valneva” or “the Company”), a biotech company developing and commercializing vaccines for infectious diseases with major unmet needs, today announced the appointment of two leading vaccine experts to its Scientific Advisory Board (SAB). Dr. Norman W. Baylor, PhD, and Dr. George R. Siber, will join Valneva’s SAB starting December 1, 2019.Dr. Norman W. Baylor is currently the President and CEO of Biologics Consulting Group, Inc. He was formerly the Director of the Office of Vaccines Research and Review (OVRR) in the US Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research. Prior to his position as Director, Dr. Baylor served as Deputy Director of OVRR and Associate...

Continue reading

Valneva annonce la nomination de deux experts des vaccins à son Conseil Scientifique

Valneva annonce la nomination de deux experts des vaccins à son Conseil Scientifique  Saint Herblain (France), 13 novembre 2019 – Valneva SE (“Valneva” ou “le Groupe”), société de biotechnologie développant et commercialisant des vaccins contre des maladies infectieuses générant d’importants besoins médicaux, a annoncé aujourd’hui la nomination de deux experts des vaccins à son Conseil Scientifique (SAB). Le Dr. Norman W. Baylor, PhD, et le Dr. George R. Siber vont rejoindre le SAB de Valneva à compter du 1er décembre 2019.Le Dr. Norman W. Baylor est actuellement Président et CEO de Biologics Consulting Group, Inc. Il était précédemment Directeur du bureau de Recherche et d’Approbation des Vaccins (OVRR) au sein du Centre de Recherche et d’Approbation des Produits Biologiques de l’agence de santé américaine Food and Drug Administration...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.